v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (985,521) $ (293,974)
Depreciation and amortization 2,605 3,523
(Gain) loss on fair value adjustment of convertible debt 36,008
Non-cash accrued Interest expense 50,939
Stock compensation expense - stock options 5,696
Stock compensation expense – issuance of common stock 30,000
Changes in assets and liabilities:    
Prepaid expenses and other current assets 89,189 (133,844)
Other assets 33,387 25,254
Accounts payable & accrued expenses (184,697) 73,172
Due to Affiliates (25,216) 11,211
Post employment benefits (278,628) 68,021
Other liabilities (122,779) (43,843)
Net cash used in operating activities (1,435,964) (203,533)
Cash flows from financing activities:    
Proceeds from issuance of convertible debt 160,000
Proceeds from sale of common stock pursuant to ATM 5,288,868
Net cash generated from financing activities 5,288,868 160,000
Effect of exchange rate changes on cash and cash equivalents (39,454) 1
Net increase (decrease) in cash and cash equivalents 3,813,450 (43,534)
Cash and cash equivalents at beginning of the period 4,982,333 101,904
Cash and cash equivalents at end of the period 8,795,783 58,370
Interest paid $ 2,845 $ 4,015

Source

10-Q XBRL Zip